ResearcherJohns Hopkins UniversityActive in the last 2 years
Alexander Ioannis Damanakis
Matched on ORCID iD 0000-0002-1155-5541; OpenAlex author ID A5070903928. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 4 papers · 2024: 2 papers · 2025: 1 paper
Papers 11
- Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion. Co-author DOI 10.1126/scitranslmed.ady7524↗
- Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-024-05681-x↗
- Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence. Co-author DOI 10.1016/j.tranon.2024.102044↗
- Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival. Co-author DOI 10.1007/s00432-023-04702-5↗
- Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer. First author DOI 10.1016/j.medj.2022.11.009↗
- Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers15072049↗
- Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. First author DOI 10.3390/cancers15245881↗
- Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13112689↗
- [Molecular predictors for the course of disease and individualized therapy in pancreatic cancer]. Co-author DOI 10.1007/s00104-020-01172-0↗
- Proposal for a definition of "Oligometastatic disease in pancreatic cancer". Co-author DOI 10.1186/s12885-019-6448-9↗
- [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy]. First author DOI 10.1007/s00104-018-0626-1↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christiane J. Bruns · 9 shared papers, 2018–2024 · strength 1.46
- Paper Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. DOI 10.3390/cancers15245881↗
- Paper Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adeno… DOI 10.1016/j.tranon.2024.102044↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Felix Popp · 6 shared papers, 2019–2024 · strength 0.90
- Paper Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adeno… DOI 10.1016/j.tranon.2024.102044↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Alexander Quaas · 6 shared papers, 2019–2024 · strength 0.90
- Paper Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adeno… DOI 10.1016/j.tranon.2024.102044↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Thomas Schmidt · 4 shared papers, 2023–2024 · strength 0.72
- Paper Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. DOI 10.3390/cancers15245881↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Su Ir Lyu · 4 shared papers, 2023–2024 · strength 0.68
- Paper Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adeno… DOI 10.1016/j.tranon.2024.102044↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Karl Knipper · 4 shared papers, 2023–2024 · strength 0.68
- Paper Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adeno… DOI 10.1016/j.tranon.2024.102044↗
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Yue Zhao · 4 shared papers, 2021–2024 · strength 0.61
- Paper Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ducta… DOI 10.3390/cancers15072049↗
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Paper Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival. DOI 10.1007/s00432-023-04702-5↗
- Florian Gebauer · 3 shared papers, 2018–2020 · strength 0.42
- Paper [Molecular predictors for the course of disease and individualized therapy in pancreatic cancer]. DOI 10.1007/s00104-020-01172-0↗
- Paper [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy]. DOI 10.1007/s00104-018-0626-1↗
- Paper Proposal for a definition of "Oligometastatic disease in pancreatic cancer". DOI 10.1186/s12885-019-6448-9↗
- Laura DeLong Wood · 2 shared papers, 2023–2025 · strength 0.37
- Paper Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasi… DOI 10.1126/scitranslmed.ady7524↗
- Paper Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic ca… DOI 10.1016/j.medj.2022.11.009↗
- Dirk Waldschmidt · 2 shared papers, 2019–2024 · strength 0.29
- Werner Hartwig · 2 shared papers, 2023–2024 · strength 0.29
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Paper Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival. DOI 10.1007/s00432-023-04702-5↗
- Utz Settmacher · 2 shared papers, 2023–2024 · strength 0.29
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Paper Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival. DOI 10.1007/s00432-023-04702-5↗
- Bettina Rau · 2 shared papers, 2023–2024 · strength 0.29
- Paper Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal a… DOI 10.1007/s00432-024-05681-x↗
- Paper Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival. DOI 10.1007/s00432-023-04702-5↗
- Isabell Wahler · 1 shared paper, 2023 · strength 0.24
- Daniel James Salas-Escabillas · 1 shared paper, 2025 · strength 0.20
- Robert A. Anders · 1 shared paper, 2025 · strength 0.20
- Jacob T. Mitchell · 1 shared paper, 2025 · strength 0.20
- Elana Judith Fertig · 1 shared paper, 2025 · strength 0.20
- Alexander T.F. Bell · 1 shared paper, 2025 · strength 0.20
- Luciane Tsukamoto Kagohara · 1 shared paper, 2025 · strength 0.20
- Katsuya Hirose · 1 shared paper, 2025 · strength 0.20
- James R. Eshleman · 1 shared paper, 2025 · strength 0.20
- Thomas Schmidt · 1 shared paper, 2024 · strength 0.20
- Pei-Hsun wu · 1 shared paper, 2023 · strength 0.17
- Jin Peng He · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.